Mucormycosis is a rare but potentially fatal angioinvasive fungal infection, caused by filamentous molds of the order Mucorales, which primarily affects immunocompromised individuals and is characterized by high mortality rates. Diabetes mellitus (DM) is the most common risk factor for mucormycosis. During the COVID-19 pandemic, the number of cases significantly increased. Mucormycosis may present in several clinical forms, but the most common form is the rhinocerebral form. This case report aims to emphasize the severity of mucormycosis in a patient with uncontrolled DM who recently recovered from COVID-19. Furthermore, this study demonstrates the importance of early diagnosis and proper treatment to prevent fatal progression. A 58-year-old man is presented in our case report; the patient was recently diagnosed with DM and presented to the outpatient department (OPD) with complaints of right eye ptosis and progressively worsening painful vision loss over 10 days. He had been infected with SARS-CoV-2 infection 15 days earlier and was treated at home with systemic corticosteroids and antibiotics. One week after recovery, he experienced spontaneous nasal bleeding, followed by progressive ocular symptoms that culminated in restricted eye movement and complete vision loss in the right eye. Physical examination revealed right eye proptosis and no light perception. Laboratory tests indicated an elevated C-reactive protein (CRP) level of 25.65 mg/dL and a significantly high glycated hemoglobin A1c (HbA1c) level of 16.3%. A tissue biopsy showed inflammatory nasal polyps associated with mucormycosis. The patient was promptly treated with insulin in order to control the elevated HbA1c and amphotericin B to stop the fungal infection and underwent extensive surgical excision. Our case highlights the severity of mucormycosis in a patient with uncontrolled DM who recently recovered from COVID-19 and shedding light on the importance of controlling the DM in order to reduce the negative impacts on the patient's health. The patient underwent proper treatment with antifungals and aggressive surgical excision to prevent more invasion of the fungi. Despite that, neurological deficits persist including complete loss of vision in one eye which reflects the importance of early diagnosis and proper management to prevent fatal progression.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11608831PMC
http://dx.doi.org/10.7759/cureus.74852DOI Listing

Publication Analysis

Top Keywords

mucormycosis patient
12
fungal infection
8
case report
8
severity mucormycosis
8
patient uncontrolled
8
uncontrolled recovered
8
recovered covid-19
8
early diagnosis
8
diagnosis proper
8
proper treatment
8

Similar Publications

BACKGROUND In several studies, the presence of Howell-Jolly body-like inclusions within neutrophils has been observed in cases of HIV infection, SARS-CoV-2 infection, post-transplant immunosuppression, and during chemotherapy or antiviral therapy. The phenomenon of neutrophils exhibiting Howell-Jolly body-like inclusions on peripheral blood smears can be attributable to viral infections or the pharmacological effects of medications. CASE REPORT A 14-year-old male patient who had received a diagnosis of lymphoblastic leukemia a year ago underwent hematopoietic stem cell transplantation and was readmitted due to a recurrence of gastrointestinal graft-versus-host disease (GVHD).

View Article and Find Full Text PDF

Rhino-Orbital-Cerebral Mucormycosis (ROCM) cases increased sharply in India during the second COVID-19 wave. Due to uncontrolled hyperglycemia, prolonged steroid use, and high ferritin levels, the immune system was dysregulated throughout this surge. Our study examined post-COVID-19 ROCM patients' T regulatory cell (Treg), T helper 17 cell (Th17) and Myeloid derived suppressor cell (MDSC) levels before and after three months of treatment.

View Article and Find Full Text PDF

Narrative review of factors associated with SARS-CoV-2 coinfection in Middle Eastern countries and the need to vaccinate against preventable diseases.

J Infect Public Health

November 2024

Adult Infectious Diseases, Department of Internal Medicine, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, P.O. Box 9515, Jeddah 21423, Saudi Arabia; King Saud bin Abdulaziz University for Health Sciences, Ministry of National Guard Health Affairs, P.O. Box 9515, Jeddah 21423, Saudi Arabia; King Abdullah International Medical Research Center, Ministry of National Guard Health Affairs, P.O. Box 9515, Jeddah 21423, Saudi Arabia. Electronic address:

This review evaluated the frequency of, and outcomes associated with, bacterial, fungal, and viral coinfection with SARS-CoV-2 in Middle Eastern countries via a PubMed search through February 2023. Ninety articles reported bacterial (n = 57), fungal (n = 32), and viral (n = 32) coinfections. High frequencies of coinfection with COVID-19 were identified, with rates and outcomes varying by setting, pathogen, surveillance/detection method, population characteristics, and drug-resistance status.

View Article and Find Full Text PDF

Combined antifungal therapy with immunostimulation for refractory cutaneous and peritoneal mucormycosis caused by Rhizopus microsporus.

Diagn Microbiol Infect Dis

December 2024

Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hospitalier St Louis-Lariboisière, Department of Anesthesiology and Critical Care and Burn Unit, Paris, France; University of Paris Cité, Paris, France; Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hospitalier St Louis-Lariboisière, France Institut National de la Santé et de la Recherche Médicale (INSERM), INSERM UMR-S 942 Mascot, Lariboisière Hospital, Paris, France; INI-CRCT Network, Nancy, France; FHU PROMICE, Paris, France. Electronic address:

Mucormycosis is a fungal infection typically affecting immunocompromised patients. Here, we report a severe case of invasive cutaneous and peritoneal mucormycosis caused by Rhizopus microsporus, successfully treated with a combination of antifungal therapy, PD-1 inhibitor, and interferon-gamma. We highlight the importance of personalized immunotherapy in refractory cases of invasive mucormycosis.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!